Articles: intubation.
-
The problems of selection of tracheal tubes, and the need for a rationale, are outlined. Tracheal tubes of 7.5 mm and 8.5 mm i.d. are recommended for female and male patients, respectively. ⋯ To provide a seal with low pressure-high volume cuffed tubes, cuff sizes of 20.5 mm and 27.5 mm are recommended for female and male patients, respectively. The mechanism of sealing with low pressure-high volume cuffs is reviewed.
-
The endotracheal route for medication is useful in emergency situations. Epinephrine, atropine, and naloxone have proved to be effective when administered by this route. Experience with lidocaine is largely anecdotal, but the available information and the drug's chemical properties indicate that endotracheal lidocaine may be considered if necessary. Drugs that should not be given by the endotracheal route include bretylium, diazepam, calcium salts, isoproterenol, norepinephrine, and sodium bicarbonate.
-
Anesthesia and analgesia · Dec 1985
Clinical Trial Controlled Clinical TrialIntravenous lidocaine as a suppressant of coughing during tracheal intubation.
Effects of intravenously administered lidocaine on cough suppression during tracheal intubation under general anesthesia were evaluated in two studies. In study 1, 100 patients received either a placebo or 0.5, 1.0, 1.5, or 2.0 mg/kg lidocaine intravenously 1 min before tracheal intubation. All visible coughs were classified as coughing. ⋯ The same criteria for determining whether a patient did or did not cough during tracheal intubation were used as in study 1. The incidence of coughing decreased significantly (P less than 0.01) when 2 mg/kg of lidocaine was injected intravenously between 1 and 5 min before our attempting intubation. Cough reflex was suppressed completely by plasma concentrations of lidocaine in excess of 3 micrograms/ml.
-
Randomized Controlled Trial Comparative Study Clinical Trial
[Vecuronium: onset of effect and intubation conditions in comparison to pancuronium and suxamethonium].
The onset of neuromuscular blockade following the i.v. injection of vecuronium and pancuronium 0.05, 0.08 or 0.1 mg/kg and suxamethonium 0.5 or 1.0 mg/kg was studied in 304 patients during induction of anaesthesia by means of the compound action potential derived from the adductor pollicis muscle, which was indirectly stimulated via the ulnar nerve. The intubation conditions 1-5 min after injection were assessed using a scoring system related to ease of laryngoscopy, movement of vocal cords and coughing, and reflex movements of extremities. Development of motor blockade was time- and dose-dependent. ⋯ Although suxamethonium acts the fastest and tracheal intubation can be achieved within 0.5-1.0 min, its use involves certain side effects and disadvantages. Vecuronium acts considerably faster than pancuronium and good or excellent intubation conditions are present within 2 min. Suxamethonium is no longer the muscle relaxant of choice for intubation except for crash intubation, e.g., in patients with a full stomach.